ARTICLE | Clinical News
ATLP-03 regulatory update
August 19, 2013 7:00 AM UTC
Atlantic said following its pre-IND meeting with FDA that it plans to develop ATLP-03, an immediate-release, abuse-deterrent formulation of pain drug oxycodone, under section 505(b)(2) of the Food, Dr...